Oric Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORIC and other ETFs, options, and stocks.About ORIC
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology.
CEOJacob M. Chacko
CEOJacob M. Chacko
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2014
Founded2014
Employees115
Employees115
ORIC Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-6.58
Price-Earnings ratio-6.58
Dividend yield—
Dividend yield—
Average volume1.27M
Average volume1.27M
High today$11.54
High today$11.54
Low today$10.72
Low today$10.72
Open price$10.91
Open price$10.91
Volume1.25M
Volume1.25M
52 Week high$14.93
52 Week high$14.93
52 Week low$3.90
52 Week low$3.90
Stock Snapshot
With a market cap of 1.11B, Oric Pharmaceuticals(ORIC) trades at $11.39. The stock has a price-to-earnings ratio of -6.58.
During the trading session on 2025-12-05, Oric Pharmaceuticals(ORIC) shares reached a daily high of $11.54 and a low of $10.72. At a current price of $11.39, the stock is +6.2% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 1.25M, compared to an average daily volume of 1.27M.
Over the past 52 weeks, Oric Pharmaceuticals(ORIC) stock has traded between a high of $14.93 and a low of $3.90.
Over the past 52 weeks, Oric Pharmaceuticals(ORIC) stock has traded between a high of $14.93 and a low of $3.90.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own ORIC. This list is generated using Robinhood data, and it’s not a recommendation.